These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 2754664)

  • 21. The role of antibiotics in Campylobacter pylori associated peptic ulcer disease.
    Bayerdörffer E; Ottenjann R
    Scand J Gastroenterol Suppl; 1988; 142():93-100. PubMed ID: 3047854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Campylobacter pylori in Swedish patients referred for gastroscopy.
    Gnarpe H; Unge P; Blomqvist C; Mäkitalo S
    APMIS; 1988 Feb; 96(2):128-32. PubMed ID: 2449900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Campylobacter pyloridis--a possible etiologic agent in patients with chronic gastritis and peptic ulcer].
    Kalenić S; Falisevac V; Gmajnicki B; Scukanec-Spoljar M; Knezević S; Vodopija I
    Lijec Vjesn; 1987 Jul; 109(7):256-60. PubMed ID: 3669886
    [No Abstract]   [Full Text] [Related]  

  • 24. Campylobacter pylori: prevalence and significance in patients with chronic renal failure.
    Offerhaus GJ; Kreuning J; Valentijn RM; Salvador Peña A; Endtz PH; van Duyn W; Lamers CB
    Clin Nephrol; 1989 Nov; 32(5):239-41. PubMed ID: 2582650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histopathological aspects of mucosal injury related to non-steroidal anti-inflammatory drugs.
    Taha AS
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():12-5. PubMed ID: 9032575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antibacterial treatment of Campylobacter pylori-associated gastritis and peptic ulcer].
    Andreasen JJ; Ringsdal VS
    Ugeskr Laeger; 1989 Apr; 151(17):1030-3. PubMed ID: 2734863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Campylobacter pylori colonization of the antrum mucosa in patients with chronic gastritis and peptic ulcer].
    Brunner H; Mittermayer H; Regele H
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():20-3. PubMed ID: 3318189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Campylobacter pylori colonization and gastroduodenal pathology].
    Gullini S; Basso O; Boccia S; Macario F; Cantarini D; Ghinelli F
    Minerva Med; 1988 Nov; 79(11):957-60. PubMed ID: 3200472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Campylobacter pylori: a newly recognized infectious agent in the gastrointestinal tract.
    Yardley JH; Paull G
    Am J Surg Pathol; 1988; 12 Suppl 1():89-99. PubMed ID: 3281485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Is Campylobacter pylori the pathogenic agent in gastritis and peptic ulcer?].
    Vráblik V; Trupl J; Pavlovic M; Horváth A; Nespor V
    Vnitr Lek; 1989 Jul; 35(7):672-8. PubMed ID: 2800373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Campylobacter pyloridis and gastroduodenal pathology].
    Thomas CM; Rosenau A; Tulliez M; Paul G; Gaudric M; Neuman M; Guerre J
    Ann Med Interne (Paris); 1987; 138(6):403-6. PubMed ID: 3434925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical, endoscopic and histologic findings in 1,100 patients of whom 574 were colonized by Campylobacter pylori].
    Deltenre M; Nyst JF; Jonas C; Glupczynski Y; Deprez C; Burette A
    Gastroenterol Clin Biol; 1989; 13(1 Pt 1):89B-95B. PubMed ID: 2744327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of Helicobacter pylori in NSAID users with gastric ulcer.
    Matsukawa Y; Aoki M; Nishinarita S; Sawada S; Horie T; Kato K; Kawamura Y; Kawamura F; Arakawa Y; Kurosaka H; Morita K; Ohtsuka E; Oribe M; Nakano M; Kitami Y
    Rheumatology (Oxford); 2003 Aug; 42(8):947-50. PubMed ID: 12730504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Helicobacter pylori infection and development of gastric or duodenal ulcer in arthritic patients receiving chronic NSAID therapy. The Misoprostol Study Group.
    Kim JG; Graham DY
    Am J Gastroenterol; 1994 Feb; 89(2):203-7. PubMed ID: 8304304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of Campylobacter pylori gastritis: a pilot study using pirenzepine dihydrochloride (Gastrozepin) and three formulations of colloidal bismuth subcitrate (De-Nol).
    Morris A; Brown P; Ali MR; Lane M; Palmer R
    N Z Med J; 1988 Oct; 101(856 Pt 1):651-4. PubMed ID: 3054641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphocytic gastritis--relationship to Campylobacter pylori infection.
    Dixon MF; Wyatt JI; Burke DA; Rathbone BJ
    J Pathol; 1988 Feb; 154(2):125-32. PubMed ID: 3258373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial.
    De Leest HT; Steen KS; Bloemena E; Lems WF; Kuipers EJ; Van de Laar MA; Bijlsma JW; Janssen M; Houben HH; Kostense PJ; Boers M; Dijkmans BA
    J Clin Gastroenterol; 2009 Feb; 43(2):140-6. PubMed ID: 18797408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-steroidal anti-inflammatory drugs (NSAID) cause gastrointestinal ulcers mainly in Helicobacter pylori carriers.
    Publig W; Wüstinger C; Zandl C
    Wien Klin Wochenschr; 1994; 106(9):276-9. PubMed ID: 8023522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Occurrence of Campylobacter pylori in patients with gastritis and peptic ulcer].
    Carneiro Leão G; Magalhães Filho M; Galvão LP; Machado RC; Padovan IP; Jucá NT; Lira VM; Magalhães M
    Arq Gastroenterol; 1988; 25(1):23-8. PubMed ID: 3223826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in Campylobacter pylori in pediatric and adult antral biopsies. A 5-year retrospective analysis.
    Veereman-Wauters G; Ferrell L; Heyman MB
    West J Med; 1989 Oct; 151(4):406-9. PubMed ID: 2588580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.